Novartis AG
Financial
Business Segments
| Segments | 2023 ($ Millions) |
|---|---|
| Cardiovascular, renal and metabolic | *** |
| Immunology | *** |
| Neuroscience | *** |
| Oncology | *** |
| Established brands | *** |
Business Segments Chart
Business Regions
| Regions | 2024 ($ Millions) |
|---|---|
| U.S. | *** |
| Europe | *** |
| Asia, Africa, Australasia | *** |
| Canada and Latin America | *** |
Business Regions Chart
This information is available for BCC Research members only.
